CJC-1295 (DAC)

Product Name:

CJC-1295 (with DAC)

Chemical Information:

• Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
• Molecular Weight: 3647.2 g/mol
• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Leu-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Ser
• Molecular Structure:

↺ + − ⛶

Product Description:

CJC-1295 (with DAC) is a synthetic peptide composed of a defined amino acid sequence and modified with a Drug Affinity Complex (DAC) component. This modification is incorporated to support structural stability and extended presence in controlled experimental systems. The compound is structurally characterized and utilized in laboratory research settings for analytical and experimental evaluation under controlled, non-clinical conditions. It is supplied in lyophilized powder form to maintain stability and integrity during storage and handling.

Research Applications:

CJC-1295 (with DAC) is utilized in controlled laboratory research settings for applications such as:

• Analytical evaluation of peptide structure and sequence characteristics
• Examination of stability and degradation profiles of modified peptide systems
• Investigation of peptide behavior in biochemical and cell-based assay environments
• Characterization of interactions of modified peptides within controlled experimental models

Storage and Handling:

• Store the lyophilized powder at -20°C.
• Once reconstituted, store at 2-8°C and use promptly.
• Use aseptic techniques during handling.

Product Specifications:

• Purity: ≥99% (HPLC Certified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in suitable laboratory agents

Compliance Notice:

CJC-1295 (with DAC) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.